Does the Incremental Shuttle Walk Test Predict the Development of a Hospital Acquired Pneumonia in Patients Undergoing Elective Oesophagectomy: A Prospective Cohort Study

NCT04440124 | Completed

• 1 other identifier: JW01
• Study Type: observational
• Target: 121
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study was to assess the predictive value of the incremental shuttle walk test on rates of hospital acquired pneumonia for patients undergoing oesophagectomy.

Conditions

Oesophageal Cancer

Keywords

physiotherapy; shuttle walk test; hospital acquired pneumonia; outcomes; oesophagectomy

Outcome Measures

Primary Outcomes (1)

• Hospital acquired pneumonia

  The incidence of hospital acquired pneumonia as defined by the US centres for Disease Control

  during hospital stay, on average 14 days

Secondary Outcomes (2)

• 30 day Mortality

  30 days after date of surgery

• 90 day Mortality

  90 days following date of surgery

Interventions

Incremental shuttle walk test OTHER

All patients were reviewed by a physiotherapist during their pre-assessment clinic one week prior to surgery to complete an incremental shuttle walk test (ISWT). The ISWT was completed according to a standardised protocol and involved patients walking around 2 cones set up 9 metres apart. Patients were asked to cover the distance between the cones in time to auditory cues. Oxygen levels and heart rate were recorded during the assessment with the use of a portable pulse oximeter. The test was stopped when patients could no longer keep pace with the auditory cues or were too breathless to continue. The total distance mobilised was recorded.

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients undergoing oesophagectomy

You may qualify if:

• Consecutive patients with a diagnosis of oesophagogastric cancer listed for an elective oesophagectomy at a large UK tertiary hospital

You may not qualify if:

• Patients who were unable to complete the walking test
• patients deemed not fit for surgery
• patients with a significant neurological event peri or post operatively

Sponsors & Collaborators

• University Hospital Birmingham NHS Foundation Trust: lead

Study Sites (1)

UHB NHS Foundation Trust

Birmingham, B15 2GW, United Kingdom

Location

MeSH Terms

Conditions

Esophageal Neoplasms; Healthcare-Associated Pneumonia

Condition Hierarchy (Ancestors)

Gastrointestinal Neoplasms; Digestive System Neoplasms; Neoplasms by Site; Neoplasms; Head and Neck Neoplasms; Digestive System Diseases; Esophageal Diseases; Gastrointestinal Diseases; Cross Infection; Infections; Pneumonia; Respiratory Tract Infections; Lung Diseases; Respiratory Tract Diseases; Iatrogenic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Consultant Physiotherapist

Study Record Dates

• First Submitted: June 14, 2020
• First Posted: June 19, 2020
• Study Start: December 1, 2017
• Primary Completion: February 1, 2020
• Study Completion: February 1, 2020
• Last Updated: June 19, 2020

Record last verified: 2020-06

Data Sharing

• IPD Sharing: Will not share

Locations

GB (1)